NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

OMG, it was editor’s choice. So much for peer review. Why does the editorial board at SNO’s Neuro-Oncology not understand the difference between time from surgery and time from randomization?

LMAO, so now SNO is incompetent.

The 2 papers did report very different OS numbers. That the first used a bogus "from surgery" date just identifies the cause of the problem.

Nor does this change the numerous other issues addressed in the paper.

The NWBO paper has probably got more critical counters in major journals than any comparable trial I can think of. And the SNO editorial board are not clowns.

How many people are you guys calling to call out for criticizing the -L P3 paper? All on the take or incompetent. Sure.

Maybe the reality is that the -L trial really was flawed?